The Current Treatment Landscape in Metastatic Prostate Cancer – Andrew Armstrong
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC The Current Treatment Landscape in Metastatic Prostate Cancer – Andrew Armstrong Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Andrew Armstrong, MD, Professor of Medicine, Professor in Surgery, Professor in Pharmacology and Cancer Biology, Director of Research, Duke…